555 related articles for article (PubMed ID: 18550603)
21. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart].
Murashita T; Yasuda K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717
[TBL] [Abstract][Full Text] [Related]
22. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
23. Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution. Improved function, metabolism, and ultrastructure.
Choong YS; Gavin JB; Buckman J
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):210-8. PubMed ID: 1735986
[TBL] [Abstract][Full Text] [Related]
24. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
Kinoshita K; Oe M; Tokunaga K
J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
[TBL] [Abstract][Full Text] [Related]
25. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three cardioplegic solutions during hypothermic ischemic arrest in neonatal blood-perfused rabbit hearts.
Konishi T; Apstein CS
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1132-7. PubMed ID: 2586132
[TBL] [Abstract][Full Text] [Related]
27. Elective cardiac surgery using Celsior or St. Thomas No. 2 solution: a prospective, single-center, randomized pilot study.
Pereda D; Castella M; Pomar JL; Cartaña R; Josa M; Barriuso C; Roman J; Mulet J
Eur J Cardiothorac Surg; 2007 Sep; 32(3):501-6. PubMed ID: 17604178
[TBL] [Abstract][Full Text] [Related]
28. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
Choong YS; Gavin JB
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
[TBL] [Abstract][Full Text] [Related]
29. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
30. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
Akita T; Abe T; Kato S; Kodama I; Toyama J
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
33. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
[TBL] [Abstract][Full Text] [Related]
34. A novel anti-oxidative agent improves recovery of the heart after cardiac arrest.
Wiklund L; Nilsson F; Sjöqvist PO; Berggren H
Thorac Cardiovasc Surg; 1994 Oct; 42(5):271-5. PubMed ID: 7863488
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts.
Qiu Y; Hearse DJ
J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777
[TBL] [Abstract][Full Text] [Related]
36. Temperature-dependent cardioprotection of exogenous substrates in long-term heart preservation with continuous perfusion: twenty-four-hour preservation of isolated rat heart with St. Thomas' Hospital solution containing glucose, insulin, and aspartate.
Shimada Y; Yamamoto F; Yamamoto H; Oka T; Kawashima Y
J Heart Lung Transplant; 1996 May; 15(5):485-95. PubMed ID: 8771504
[TBL] [Abstract][Full Text] [Related]
37. Multi-dose crystalloid cardioplegia preserves intracellular sodium homeostasis in myocardium.
Schepkin VD; Choy IO; Budinger TF; Young JN; DeCampli WM
J Mol Cell Cardiol; 1999 Sep; 31(9):1643-51. PubMed ID: 10471348
[TBL] [Abstract][Full Text] [Related]
38. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' Hospital solution during prolonged ischemia.
Jayawant M; Stephenson ER; Damiano RJ
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):131-8. PubMed ID: 9671907
[TBL] [Abstract][Full Text] [Related]
39. Cardioplegic protection of hearts with pre-arrest ischaemic injury: effect of glucose, aspartate, and lactobionate.
Choong YS; Gavin JB; Cottier DS
Thorac Cardiovasc Surg; 1995 Dec; 43(6):331-7. PubMed ID: 8775858
[TBL] [Abstract][Full Text] [Related]
40. Poststorage diastolic abnormalities of heart transplants: is vascular dysfunction or myocardial contracture the culprit?
Kevelaitis E; Mouas C; Menasché P
J Heart Lung Transplant; 1996 May; 15(5):461-9. PubMed ID: 8771501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
